# NorthStar Medical Radioisotopes orders two additional Rhodotron accelerators from IBA

NorthStar Medical Radioisotopes has signed an agreement to purchase two additional Rhodotron TT300 HE electron beam accelerators from IBA for the production of molybdenum-99 at its Beloit, Wisconsin headquarters. This brings the total to five accelerators purchased from IBA.

- Type: Contract
- Announced: 2022-09-20
- Where: Beloit, Wisconsin, United States
- Status: announced
- Products: Rhodotron TT300 HE electron beam accelerators, molybdenum-99
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [IBA S.A.](https://endata.com/companies/44009.md) (supplier)
- [NorthStar Medical Radioisotopes](https://endata.com/companies/53696.md) (customer)

## Sources

- [globenewswire.com](https://www.globenewswire.com/en/news-release/2022/09/20/2518797/0/en/NorthStar-Medical-Radioisotopes-and-IBA-Sign-Agreement-for-Two-Additional-Rhodotron-Electron-Beam-Accelerators-for-Commercial-Production-of-Radioisotopes.html/), 2022-09-20: "NorthStar continues to invest in the future of nuclear medicine using innovative technology to advance environmentally sustainable radioisotope production."
- [globenewswire.com](https://www.globenewswire.com/news-release/2022/09/20/2518797/0/en/northstar-medical-radioisotopes-and-iba-sign-agreement-for-two-additional-rhodotron-electron-beam-accelerators-for-commercial-production-of-radioisotopes.html/), 2022-09-20: "NorthStar continues to invest in the future of nuclear medicine using innovative technology to advance environmentally sustainable radioisotope production."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.